Results 151 to 160 of about 6,049 (169)

Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System

Journal of Clinical Medicine, 2023
Background: Febuxostat and allopurinol are the most commonly used uric acid-lowering medications, and their safety is of great concern, especially the cardiovascular adverse reactions associated with febuxostat.
Bin Wu, Yang Bai, Tiejun Zhang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis

Clinical Cardiology, 2021
Ying Pan, Linggen Gao
exaly  

Formulation Development of Fast Dissolving Microneedles Loaded with Cubosomes of Febuxostat: In Vitro and In Vivo Evaluation

Pharmaceutics, 2023
Hetal Thakkar
exaly  

Efficacy and tolerability of febuxostat in gout patients on dialysis

Internal Medicine Journal, 2021
Doo-Ho Lim, Sunggun Lee, Seung Choi
exaly  

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.

European Heart Journal, 2019
Yoshihiko Saito, Kunihiko Matsui, Kazuo Kimura   +2 more
exaly  

Formulation, optimization and – evaluation of febuxostat nanosuspension

International Journal of Pharmaceutics, 2015
Sarasija Suresh
exaly  

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.

Rheumatology, 2009
M A Becker, H R Schumacher
exaly  

Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment

Joint Bone Spine, 2016
Hang Korng Ea, Thomas Bardin, Tristan Pascart   +2 more
exaly  

Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects

British Journal of Clinical Pharmacology, 2008
Reza Khosravan, Nancy Joseph-Ridge, Laurent Vernillet   +2 more
exaly  

Efficacy and Tolerability of Febuxostat in Hyperuricemic Patients With or Without Gout: A Systematic Review and Meta-Analysis

Clinical Therapeutics, 2013
Qifu Li, Qingfeng Cheng, Ting Luo
exaly